Physician profile
Atom Sarkar
NPI 1437109584
$27,705.30
in general payments reported to CMS, 2019-2025
12 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $1,416 · 2021: $1,288 · 2022: $8,884 · 2023: $15K · 2024: $500 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $13K · Consulting Fee: $3,025 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $12,561.42 |
| Consulting Fee | $3,025.00 |
| Food and Beverage | $422.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altus Partners. LLC | $20,577.61 | 2021-2023 | Altus Spine Sochi Oct Spinal System |
| Longeviti Neuro Solutions INC | $3,431.27 | 2022-2023 | |
| Integra Lifesciences Corporation | $1,511.17 | 2019-2024 | Codman Certas, Cusa Clarity, Surgimend |
| Canon Medical Systems USA, INC. | $1,192.50 | 2020 | |
| Novocure INC. | $308.21 | 2023-2025 | Optune Gio, Optune |
| Medtronic, INC. | $171.73 | 2021-2025 | Percept PC Brainsense |
| Nevro Corp. | $147.50 | 2020 | |
| Zap Surgical Systems, INC. | $117.94 | 2022 | |
| Abbott Laboratories | $87.12 | 2019 | |
| Medtronic USA, INC. | $76.00 | 2020 | |
| Siemens Medical Solutions USA, INC. | $73.46 | 2022 | |
| Zimmer Biomet Holdings, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atom Sarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.